Biogen Idec Inc $341.73

up +5.34


29/7/2014 04:00 PM  |  NASDAQ : BIIB  
Industries : Drugs / Biotechnology
Get Trend Analysis Icon Get BIIB Trend Analysis - it has outperformed the S&P 500 by 41%

Partner Headlines

  1. Ken Fisher's Top Increaes of the Second Quarter

    GuruFocus
  2. Ken Fisher's Top Increases of the Second Quarter

    GuruFocus
  3. Chipotle, Facebook Rally On Upside Earnings Surprise

    IBD
  4. Celgene, Alexion Beat Estimates, But Biotechs Fall

    IBD
  5. Celgene, Alexion Earnings Top Street, But Stocks Fall

    IBD
  6. Biogen, Gilead Profits Soar

    IBD
  7. Biogen, Gilead Crush Earnings Estimates On Hot Drugs

    IBD
  8. S&P 500 Posts New High; Biotechs, Airlines, Builders Up

    IBD
  9. IPO Stock Watch: Biotechs Are Half Of July Calendar

    IBD
  10. Vertex Is Poised For An Earnings Breakout

    Benzinga
  11. Pepsi Beats; Positive Phase 3 Breast Cancer Data Creates Potential Buyout ...

    Benzinga
  12. S&P 500 Flirts With High; Breadth Missing On Nasdaq

    IBD
  13. Intuitive Surgical Rises On Upbeat Earnings; Xilinx Shares Slip

    Benzinga
  14. S&P 500 Aims At New High; Biotechs Gap Up In Fast Trade

    IBD
  15. Biogen Trounces Q2 Estimates As Tecfidera Outperforms

    IBD
  16. Apple, Microsoft Lead Nasdaq Higher; Dow Falters

    IBD
  17. Markets Mixed; PepsiCo Q2 Earnings Beat Street View

    Benzinga
  18. Stocks: Mixed Open, Mixed Trade; Delta, Broadcom, Biogen Buck Up

    IBD
  19. Morning Market Movers

    Benzinga
  20. UPDATE: Biogen Idec Posts Stronger-Than-Expected Q2 Results, Shares Surge

    Benzinga
  21. Stock Futures Up, But Wobbly; Boeing, Apple, Biogen Rising

    IBD
  22. Benzinga's Top #PreMarket Gainers

    Benzinga
  23. Earnings Scheduled For July 23, 2014

    Benzinga
  24. Stocks Rise; Apple, Microsoft Steady In Post-Session

    IBD
  25. Alexion, 3 Other Top Biotechs Reporting Earnings

    IBD
  26. Stocks Climb In Solid Trade; Chipotle Gaps Up, Breaks Out

    IBD
  27. Oil Dominates; Keurig, Constellation Near Buy Points

    IBD
  28. IBD 50 Ends Week Lower But Skyworks Soars

    IBD
  29. Biogen Shares Rebound As Street Has A Change Of Heart

    IBD
  30. Facebook, Gilead Headline IBD 50's Top 5 Earnings

    IBD
  31. IBD 50 Ends Week Lower But Skyworks Soars

    IBD
  32. Biotech Enters Reporting Season With Large Caps Central To Sector Performance

    Benzinga
  33. Baxter Q2 Earnings Beat Estimates, But Guidance Soft

    IBD
  34. IBD Big Cap 20 Leaders Hold Up Well Despite Shaky Market

    IBD
  35. Biogen's Profit Rolls Amid Recent Drug Launches

    IBD
  36. Stocks Close Higher As Biotech, Internet Stocks Gain

    IBD
  37. Deutsche Bank Analyst Talks Up Biogen On CNBC; Stock Responds Slightly

    Benzinga
  38. Alexion Pharma Looks To Life Beyond Its Blockbuster

    IBD
  39. Citi Sees Plenty Of Q2 Earnings Beats Ahead In Biotech Sector

    Benzinga
  40. Biogen Hemophilia Drugs Launch Into The Unknown

    IBD
  41. Top 4 Stocks In The Biotechnology Industry With The Highest EPS

    Benzinga
  42. AbbVie, Shire Give Bullish Guidance Amid Buyout Talk

    IBD
  43. ISIS Pharma Trades Up Premarket; NYT Says Has Potential Heart Attack Drug

    Benzinga
  44. Benzinga's M&A Chatter for Monday June 16, 2014

    Benzinga
  45. Biogen, AbbVie Report Positive Top-Line Results from Phase 3 Trial of Daclizumaba ...

    Benzinga
  46. 50-Day Moving Average Can Buffer A Strong Stock's Advance

    IBD
  47. UPDATE: Morgan Stanley Reiterates On Biogen Idec As Positive RPC1063 Data ...

    Benzinga
  48. Stock Indexes Slightly Up; Apple Split Takes Effect

    IBD
  49. UPDATE: Morgan Stanley Reiterates On Biogen Idec Following Good News On ...

    Benzinga
  50. US Stock Futures Slightly Lower Ahead Of McDonald's Sales Report

    Benzinga
Trading Center